Related references
Note: Only part of the references are listed.Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial
Frederic Bouisset et al.
JAMA CARDIOLOGY (2023)
PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology
Vincenzo Quagliariello et al.
CANCERS (2023)
2023 ESC Guidelines for the management of acute coronary syndromes
Robert A. Byrne et al.
EUROPEAN HEART JOURNAL (2023)
Diagnosis and Treatment of Acute Coronary Syndromes A Review
Deepak L. Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction The PACMAN-AMI Randomized Clinical Trial
Lorenz Raber et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach
Linan Zeng et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2022)
Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis
Frederic C. Daoud et al.
BIOMEDICINES (2022)
Use of Thrombus Aspiration for Patients With Acute Coronary Syndrome: Insights From the Nationwide J-PCI Registry
Taku Inohara et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)
Individual Patient Data Meta-analysis of Drug-eluting Versus Bare-metal Stents for Percutaneous Coronary Intervention in Chronic Versus Acute Coronary Syndromes
Raffaele Piccolo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2022)
The changing landscape of atherosclerosis
Peter Libby
NATURE (2021)
Temporal trends in incidence and outcome of acute coronary syndrome
Johannes T. Neumann et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome The Randomized TIDES-ACS Trial
Pim A. L. Tonino et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
Vincenzo Quagliariello et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka
Udaya Ralapanawa et al.
BMC CARDIOVASCULAR DISORDERS (2019)
Standardized End Point Definitions for Coronary Intervention Trials
Hector M. Garcia-Garcia et al.
EUROPEAN HEART JOURNAL (2018)
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial
Olivier Varenne et al.
LANCET (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prévalence et caractéristiques des syndromes coronariens aigus dans une population d’Afrique subsaharienne
R. N’Guetta et al.
ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE (2016)
Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial
Pasi P. Karjalainen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial
Manel Sabate et al.
LANCET (2016)
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
K. H. Bonaa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction
Wouter S. Remkes et al.
OPEN HEART (2016)
Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
Marco Valgimigli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
Philip Urban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation
Thomas Pilgrim et al.
EUROINTERVENTION (2015)
Long-term comparison of sirolimus-eluting and bare-metal stents in ST-segment elevation myocardial infarction
Inge Wijnbergen et al.
CORONARY ARTERY DISEASE (2014)
The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: A substudy of the COMFORTABLE AMI trial
Michael Magro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention
Marco Valgimigli et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
A Prospective Randomized Trial of Everolimus-Eluting Stents Versus Bare-Metal Stents in Octogenarians
Adam de Belder et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial
Expedito E. Ribeiro et al.
EUROINTERVENTION (2014)
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
Jelena Savovic et al.
SYSTEMATIC REVIEWS (2014)
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: Long-term follow-up from the TITAX AMI trial
Petri O. Tuomainen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Long-term outcome of sirolimus-eluting vs bare-metal stent in the setting of acute myocardial infarction: 5-year results of the SESAMI trial
Carmine Musto et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)
Marco Valgimigli et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction 5 Years Follow-Up From the Randomized DEDICATION Trial (Drug Elution and Distal Protection in Acute Myocardial Infarction)
Lene Holmvang et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
First Results of the DEB-AMI (Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction) Trial A Multicenter Randomized Comparison of Drug-Eluting Balloon Plus Bare-Metal Stent Versus Bare-Metal Stent Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention With 6-Month Angiographic, Intravascular, Functional, and Clinical Outcomes
Anouar Belkacemi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
Manel Sabate et al.
LANCET (2012)
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial
Pedro A. Lemos et al.
EUROINTERVENTION (2012)
A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial
Pasi P. Karjalainen et al.
EUROINTERVENTION (2012)
Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents
J. Ribamar Costa et al.
EUROINTERVENTION (2012)
Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI
David D. McManus et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Four-Year Follow-Up of TYPHOON (Trial to Assess the Use of the CYPHer Sirolimus-Eluting Coronary Stent in Acute Myocardial Infarction Treated With BallOON Angioplasty)
Christian Spaulding et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Comparison of Titanium-Nitride-Oxide Coated Stents With Zotarolimus-Eluting Stents for Coronary Revascularization A Randomized Controlled Trial
Thomas Pilgrim et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
5-Year Follow-Up After Primary Percutaneous Coronary Intervention With a Paclitaxel-Eluting Stent Versus a Bare-Metal Stent in Acute ST-Segment Elevation Myocardial Infarction A Follow-Up Study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction With ST-Segment Elevation) Trial
Maarten A. Vink et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
GRADE guidelines: 8. Rating the quality of evidence-indirectness
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 5. Rating the quality of evidence-publication bias
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines 6. Rating the quality of evidence-imprecision
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial
Gregg W. Stone et al.
LANCET (2011)
Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial
Pasi Karjalainen et al.
EuroIntervention (2011)
Three-Year Outcome of Sirolimus-Eluting Versus Bare-Metal Stents for the Treatment of ST-Segment Elevation Myocardial Infarction (from the MISSION! Intervention Study)
Jael Z. Atary et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Role of the Paclitaxel-Eluting Stent and Tirofiban in Patients With ST-Elevation Myocardial Infarction Undergoing Postfibrinolysis Angioplasty The GRACIA-3 Randomized Clinical Trial
Pedro L. Sanchez et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
Strut Coverage and Vessel Wall Response to Zotarolimus-Eluting and Bare-Metal Stents Implanted in Patients With ST-Segment Elevation Myocardial Infarction The OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study
Giulio Guagliumi et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries
Christoph Kaiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction.
Robert W. Yeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial
Nicolaus Reifart et al.
EUROINTERVENTION (2010)
Interleukin 8 and cardiovascular disease
Stavros Apostolakis et al.
CARDIOVASCULAR RESEARCH (2009)
The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial
Emilio Di Lorenzo et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)
Eric L. Eisenstein et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
In-stent restenosis in bare metal stents versus sirolimus-eluting stents after primary coronary intervention for acute myocardial infarction and subsequent transcoronary transplantation of autologous stem cells
Clemens Steinwender et al.
CLINICAL CARDIOLOGY (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Single-Center Randomized Evaluation of Paclitaxel-Eluting Versus Conventional Stent in Acute Myocardial Infarction (SELECTION)
Tania Chechi et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2007)
Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty
Luis-S Diaz de la Ilera et al.
AMERICAN HEART JOURNAL (2007)
Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome:: Serial angiographic and sonographic analysis
Andreas Koenig et al.
AMERICAN HEART JOURNAL (2007)
Firebird sirolimus eluting stent versus bare mental stent in patients with ST-segment elevation myocardial infarction
Gao Hai et al.
CHINESE MEDICAL JOURNAL (2007)
A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints
Roger M. Harbord et al.
STATISTICS IN MEDICINE (2006)
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine encapsulated stent for treatment of native coronary artery lesions:: Clinical and angiographic results of the ENDEAVOR II trial
Jean Fajadet et al.
CIRCULATION (2006)
Systematic reviews in health care - Investigating and dealing with publication and other biases in meta-analysis
JAC Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Share Paper
